RA Capital Nexus Fund II, L.P.
CIK 1825376 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ELYM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEPG | Director | — | $2.49 | — | $0 | 2 | 2026-06-22 |
| LENZ | Director | — | $3.15 | — | $0 | 2 | 2026-06-15 |
| JANX | Director | 1,048,406 | $16.69 | $17.50M | $0 | 4 | 2025-06-13 |
| Climb Bio, Inc. (ELYM) Delisted | Director | 841,087 | $5.11 | $4.30M | $349.67M | 1 | 2024-07-01 |
| HOWL | Director | — | $0.98 | — | $0 | 1 | 2024-05-24 |
| ACRV | Director | 7,914,206 | $1.72 | $13.61M | $0 | 1 | 2024-04-15 |
| Icosavax, Inc. (ICVX) Delisted | Director | 0 | $15.31 | $0 | $4.18M | 2 | 2024-02-20 |
| SPRY | Director | 8,556,774 | $3.92 | $33.54M | $40.92M | 1 | 2023-09-25 |
| DICE | Director | 6,848,911 | $22.25 | $152.41M | $299.30M | 1 | 2022-10-19 |
| ANTX | 10%+ Owner | 3,748,087 | $3.63 | $13.61M | $3.24M | 1 | 2022-06-15 |
Recent Filings · Page 2 of 2
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-06 | JANX | Buy (P) | — | $0 | EDGAR |
| 2024-02-20 | Icosavax, Inc. (ICVX) Delisted | Mixed | −29,845,540 | $0 | EDGAR |
| 2023-09-25 | SPRY | Buy (P) | +13,500,000 | $40.92M | EDGAR |
| 2023-06-16 | JANX | Grant (A) | — | $0 | EDGAR |
| 2022-10-19 | DICE | Buy (P) | +8,200,000 | $299.30M | EDGAR |
| 2022-06-15 | ANTX | Buy (P) | +407,120 | $3.24M | EDGAR |
| 2022-03-30 | Icosavax, Inc. (ICVX) Delisted | Buy (P) | +921,090 | $4.18M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.